creation date: 2026-01-22 21:03
tags: Pathologies


Precocious Puberty

Background

Definitions

Precocious puberty, or early puberty, is defined as the onset of puberty 2-2.5 standard deviations below the mean age of onset of puberty (10.5 and 11.5 for females and males, respectively).

  • Onset of breast development before age 8 in females
  • Onset of testicular enlargement before age 9 in males

Etiology and Pathophysiology

Causes of precocious puberty can be classified by the underlying pathologic process.

Central precocious puberty
CPP, also known as gonadotropin-dependent precocious puberty or true precocious puberty, is caused by early maturation and activation of the hypothalamic-pituitary-gonadal axis. Causes include:

  • Idiopathic (80-90% in females, 25-80% in males)
  • CNS tumours or irradiation
  • Pituiary gonadotropin-secreting tumours

Peripheral precocious puberty
Also known as peripheral percocity or gonadotropin-independent precocious puberty, is caused by excess sex hormone either from the gonads or adrenal glands, or from exogenous sources.

  • Ovarian cysts (female)
  • Ovarian tumours (female)
  • Leydig cell tumour (male)
  • hCG-secreting germ cell tumours (male)
  • Primary hypothyroidism
  • Exogenous estrogen/androgen such as caretaker’s topical ointment, foods, and OTC remedies
  • Adrenal conditions such as tumours, congenital adrenal hyperplasia

Benign or nonprogressive pubertal variants
This category includes cases of early development of secondary sex characteristic but without underlying pathology nor progressive development.

May be idiopathic (as with premature thelarche) or transient activation of the HPA axis.

Clinical Presentation

Signs & Symptoms

Findings of secondary sex characteristics and the normal order of occurrence are as follows.

Male

  1. Testes enlargement
  2. Pubic hair growth
  3. Growth spurt (average age of 13)
  4. Spermarche

Female

  1. Breast development
  2. Pubic hair growth
  3. Growth spurt
  4. Menarche

Other evidence of linear growth acceleration include:

  • Headaches
  • Changes in behaviour or vision
  • Seizures
  • Abdominal pain

History & Physical Exam

History should focus on timing of development and sequence of characteristic developments.

Assessment of potential underlying causes such as exogenous hormones should be performed.

Physical exam includes height, weight, and height velocity. A neurologic exam with visual fields should be included for the possibility of a CNS mass.

Risk factors

Diagnosis

Criteria

Diagnosis is made with evidence of progressive pubertal development prior to age 8 for females and age 9 for males.

Work-up

For patients with progressive pubertal development of suspicion of precocious puberty.

Initial testing

  • LH, FSH
  • Estradiol in females
  • Testosterone (AM) in males
  • Bone age

Further workup
A number of further laboratory studies can be performed based on the results of the above findings. In general, unexpected findings, signs of androgen excess, or features of genetic disorders warrant referral and workup.

Imaging
In all males with CPP and females aged <6 with CPP, brain MRI is indicated due to high rates of CNS abnormalities.

Pelvic ultrasound may also aid with evaluation.

Red Flags / Complications

The major complication of precocious puberty is loss of growth potential due to premature fusing of growth plates (at end of puberty).

Management

Management is made by pediatric endocrinologist. The goal of treatment is to halt puberty.

For CPP, this consist of GnRH agonist therapy, which following an initial activation will provide negative feedback, effectively suppressing the pituitary-gonadal axis reversibly.

For peripheral precocity, GnRH agonist does not work and thus therapy targets the cessation of production of sex steroids and/or the response to the sex steroids.

References

Tools / Guidelines

Additional Reading